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Background: Immediate implant-based breast reconstruction (IBBR) is the most commonly performed
reconstructive procedure in the UK, but almost one in ten women experience implant loss and recon-
structive failure after this technique. Little is known about how implant loss impacts on patients’ quality of
life. The first phase of the Loss of implant Breast Reconstruction (LiBRA) study aimed to use qualitative
methods to explore women’s experiences of implant loss and develop recommendations to improve care.
Methods: Semistructured interviewswere conductedwith a purposive sample of womenwho experienced
implant loss after immediate IBBR, performed for malignancy or risk reduction across six centres.
Interviews explored decision-making regarding IBBR, and experiences of implant loss and support
received. Thematic analysis was used to explore the qualitative interview data. Sampling, data collection
and analysis were undertaken concurrently and iteratively until data saturation was achieved.
Results: Twenty-four womenwere interviewed; 19 had surgery formalignancy and five for risk reduction.
The median time between implant loss and interview was 42 (range 22–74) months. Ten women
had undergone secondary reconstruction, two were awaiting surgery, and 12 had declined further
reconstruction. Three key themes were identified: the need for accurate information about the risks and
benefits of IBBR; the need for more information about ‘early-warning’ signs of postoperative problems,
to empower women to seek help; and better support following implant loss.
Conclusion: Implant loss is a devastating event for many women. Better preoperative information and
support, along with holistic patient-centred care when complications occur, may significantly improve
the experience and outcome of care.
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Introduction
Breast cancer currently affects over 55 000 women per
year in the UK1 and, despite improvements in treatment,
up to 40 per cent require a mastectomy as the primary
surgical treatment for their disease2. Loss of the breast
may profoundly affect a woman’s body image and quality
of life3–6, and in the UK breast reconstruction is offered
routinely to improve outcomes7.
Immediate implant-based breast reconstruction (IBBR)
is the most commonly performed reconstructive procedure
in both the UK8 and the USA9. It may offer women the
benefits of a quick procedure with rapid recovery and
good cosmetic results, without the morbidity associated
with harvesting tissue from elsewhere10. Traditionally
performed as a two-stage procedure, involving tissue
expansion followed by the insertion of a fixed-volume
implant10, the practice of IBBR has evolved significantly
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in recent years with the introduction of new techniques
to augment the subpectoral pocket with a biological or
synthetic mesh or the patient’s own de-epithelialized
skin11. The addition of mesh creates a more ptotic,
natural-looking breast through better lower-pole projec-
tion, and allows the procedure to be performed in a single
stage12–16. These additional benefits have broadened the
indications for IBBR and resulted in increasing numbers
of women electing to undergo the technique17.
Despite the benefits of immediate IBBR, up to 10 per
cent of women undergoing the procedure may experi-
ence implant loss due to complications such as infec-
tion or skin-flap necrosis18. Implant loss leading to failure
of the reconstruction is distressing for patients and sur-
geons, and has significant resource implications for health-
care providers19. Although rates of implant loss are often
reported in the literature20, few studies have explored
the impact of this potentially devastating complication on
women’s quality of life, or reported how implant loss is
managed subsequently. Given the increasing numbers of
women electing to undergo immediate IBBR who may
potentially experience implant loss, there is an urgent need
to understandwomen’s experiences to provide patients with
better information and support in the future.
Qualitative research aims to understand in depth ‘why’
and ‘how’ events arise rather than ‘how many’ occur21–23,
and is a useful approach for exploring sensitive health
issues such as implant loss. It is also suitable for conducting
research that examines patient–clinician communication,
how this is negotiated, and its meaning to individuals in
health contexts22. Qualitative data can generate greater
insights into individuals’ perceptions of care and enable
important issues to be explored by helping to develop a
detailed understanding of how and why problems exist
in different contexts24,25. These data can also be used
to gather information about the meanings and emotions
interviewees ascribe to interpersonal processes in specific
contexts that are difficult to observe through alternative
methods26,27.
The aim of this study was to use qualitative methods to
explore the experiences of women who had experienced
implant loss after immediate IBBR as the first phase of
the LiBRA study, which aimed to use mixed methods
to develop better information and support for patients
experiencing this complication in the future.
Methods
This qualitative work formed the first part of the LiBRA
study. Its findings will inform the design of a question-
naire that will allow the process and outcomes of care for
patients experiencing implant loss to be explored further.
The study received ethical approval from the South-West
Central Ethics Committee (reference 16/SW/0115). The
study was conducted in accordance with the Declara-
tion of Helsinki. It was registered (researchregistry1002)
prospectively before data collection commenced, and has
been reported according to the COnsolidated criteria for
REporting Qualitative research (COREQ) guidelines28.
All patients provided written informed consent before par-
ticipation in the study.
Recruitment
Eligible patients were identified from six breast and
plastic surgical units in the English National Health
Service (NHS) through liaison with consultant breast
and plastic surgeons, clinical nurse specialists, and review
of departmental databases. Sampling was purposive to
allow maximum variation of participant ages, indication
for surgery (malignancy versus risk reduction), time from
initial reconstruction to implant loss, decisions regarding
subsequent reconstructive procedures (none, implant or
autologous) and pathways of care (local management or
referral to regional centres).
Women were eligible to take part in the study if they had
undergone immediate implant-only reconstruction follow-
ing mastectomy for malignancy or risk reduction between
January 2010 andDecember 2015, and subsequently devel-
oped infection, skin necrosis or another complication that
necessitated surgical removal of the expander or implant
within 9months of the initial reconstructive surgery. Nine
months was agreed by the study steering group as changes
in IBBR techniques have resulted in implant loss occur-
ring later than observed previously29. Women who had
undergone a planned two-stage procedure and lost their
fixed-volume implant after the second stage were also eligi-
ble.Women who had a fixed-volume implant replaced with
a tissue expander or other salvage procedure not resulting
in the complete removal of the prosthesis were excluded.
An invitation letter with a reply slip and patient informa-
tion sheet were sent to potential participants by the surgeon
responsible for their care.Women who chose to participate
were asked to return the reply slip with contact details to
the study team so they could be contacted by telephone or
e-mail to arrange an interview. Sampling, data collection
and analysis were conducted iteratively and concurrently
as the study progressed, until data saturation was achieved.
Data collection
Semistructured telephone interviews were conducted by a
member of the research team, a female qualified chartered
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psychologist with no previous involvement with patients
with breast cancer, using a topic guide developed by the
study steering group based on a review of the literature and
their collective experience as surgeons and psychologists
(Appendix S1, supporting information). The interviewer
was independent of the clinical teams providing patient
care, and this was explained to study participants before
commencing the interview. Telephone interviews are suit-
able for research conducted with participants who live in
geographically diverse locations and, compared with inter-
views conducted face-to-face, can encourage interview-
ees to talk more openly about sensitive issues because they
are on their ‘own turf’, with greater privacy and some
degree of anonymity30.
The topic guide explored women’s rationale for deciding
to undergo immediate IBBR (primary reconstruction and,
if appropriate, decision-making for secondary reconstruc-
tion), and their perceptions of how implant loss affected
them and the support they received from healthcare
professionals during and after losing the implant. The
topic guide was modified iteratively as the interviews
progressed to allow emerging themes to be explored.
Interviews were conducted at a time convenient to the
study participant, and written consent was obtained before
each interview. Each interview lasted for 60–90minutes
and was audio-recorded digitally, transcribed in full, and
checked by the study team for accuracy against the original
recording. All transcripts were anonymized to protect
patient confidentiality. No repeat interviews were per-
formed. Field notes were made during the interviews, and
taken into account during the analysis.
Analysis
Analysis of the interviews was an ongoing iterative process,
commencing soon after data collection and informing
further sampling. Transcripts were analysed thematically
in batches of two to four using the data analysis package
NVivo (https://www.qsrinternational.com/nvivo/home),
and informed by the constant comparison technique of
grounded theory31–33. Themes drawn from the data rep-
resent distinct patterns, comprised of smaller extracts of
information or ‘codes’. The analytical procedure under-
taken with the first batch of transcripts was as follows:
working independently, two members of the research
team familiarized themselves with the transcripts in full,
annotating early ideas about potential codes. Data were
then analysed on a line-by-line basis to identify codes
considered to enhance understanding of the a priori topic
guide issues. Codes were then collated on the basis of
shared, or similar, meaning in the data, and grouped
into themes. Emerging themes and interpretation were
presented to, and discussed with, clinical members of the
study team (2 breast surgeons and 1 plastic surgeon) at
several points within the study to check plausibility and
triangulate findings with clinical experience. Sampling,
data collection and analysis were undertaken concurrently
and iteratively until data saturation was achieved and no
new codes or themes were identified32.
Themes emerging from the study, together with
examples of good clinical care described by interview
participants, were used to develop recommendations to
improve the experiences of patients who had implant loss
in the future. Proposed strategies were discussed with
the study team to determine the feasibility of implemen-
tation, explored with interview participants as the study
progressed, and iteratively modified until no new potential
improvements in care were identified.
Results
Sixty-eight women from six centres were invited to par-
ticipate in the study. Of these, 28 returned a completed
consent form and 24 were interviewed successfully.
Characteristics of participants are summarized in Table 1.
The majority of women (19) underwent mastectomy for
breast cancer. Participants in the risk-reducing group
were younger (median age 33 (range 25–40) years) and
more likely to pursue secondary reconstruction than those
having surgery for malignancy (median age 59 (range
41–74) years). Half of the total sample declined further
reconstructive procedures after their experience of implant
loss. Secondary reconstructions were most commonly
implant-based (8), with fewer patients (2) opting to have
an autologous procedure. The median time between
implant loss and study participation was 42months (range
22–74months).
Three key themes emerged regarding women’s expe-
riences of IBBR and implant loss. These were broadly
similar irrespective of the indication for surgery: having
realistic, accurate information about the risks and benefits
of implant-based reconstruction to allow patients to make
informed decisions about reconstructive surgery; knowing
the ‘early warning’ signs of postoperative problems to
empower patients to seek help; and the need for ongoing
support after implant loss.
The need for realistic, accurate information about
risks and benefits of implant-based reconstruction
to inform decision-making
All women described how their surgeons presented
implant-based reconstruction more positively than other
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Table 1 Demographics of the 24 women participating in the LiBRA study
Total sample
(n = 24)
Malignancy
(n = 19)
Risk reduction
(n = 5)
Age (years)* 54 (25–74) 59 (41–74) 33 (25–40)
Length of interview (min)* 66 (41–89) 67 (49–89) 64 (41–89)
Time from loss of implant after primary reconstruction at interview (months)* 42 (22–74) 48 (23–74) 41 (22–48)
Secondary reconstruction
Received secondary reconstruction 10 6 4
Implant-based 8 4 4
Flap-based 2 2 0
Time from secondary reconstruction (months)* 37 (4–68) 38 (4–68) 37 (25–42)
Awaiting secondary reconstruction 2 1 1
Declined further reconstruction 12 12 0
*Values are median (range).
forms of reconstruction in preoperative consultations, and
that this influenced their decision to opt for the procedure.
‘I just didn’t want to be lying about … you’re in hospital
a lot longer with the back flap… recovery time is much
worse … The mastectomy, followed by the implant, was
the quickest way I could get back on my feet’
Patients’ focus on a procedure that offered fast recovery
was motivated by their desire to regain a sense of physical,
psychological and social normality, and these factors were
central to their decision to opt for IBBR.
‘… you know I wanted to look normal … I wanted to
feel like a woman’
Women who were considering surgery following a new
breast cancer diagnosis also reported a sense of urgency
about the decision.
‘They want you to do everything quickly … from diag-
nosis to surgery, I think there were some number of weeks
… that they needed to comply with … there was a sort of
urgency about it.’
This often resulted in womenmaking quick decisions about
surgery based on what was presented as the ‘easiest’ and
‘quickest’ option by their surgical team. On reflection,
some women felt they perhaps should have explored their
options more fully, but did not feel able to do so at the time.
‘If somebody’s talking statistics, I’m probably just think-
ing, “Actually, I want my cancer out. Can you just fix
me?” If anybody had said to me at that time, “We can
fix your cancer, but we need to chop your left arm off,”
I’d have probably just said, “Do it” … your whole sense
of normality is huge. You’re fighting for your life. You’ve
been told you’ve got cancer’
Women’s decisions for implant reconstruction were par-
ticularly influenced by their surgeon’s optimism that the
procedure would be successful.
‘… the surgeon was very optimistic … so I don’t think I
explored … any other issues that might ensue’
Some women could not recall the risk of implant loss and
reconstructive failure being discussed.
‘I suppose I didn’t realise the number of [implant losses],
I’m not sure whether they know that, or they’re supposed
to tell you that. I didn’t know how many implants actually
failed’
Others described discussing potential risks, but explained
that their surgeon explored this with them, and they felt
reassured.
‘There’s risk involved in anything, however this …
doesn’t look too bad, so I’ll go for it … It was just that
positiveness … I had every right to be really sure of (my
surgeon)’
Although women undergoing risk-reducing surgery did
not perceive the same urgency regarding decision-making
for surgery, they – and some patients undergoing surgery
for breast cancer – described how it was difficult to con-
ceptualize risk and what that meant for them.
‘… like many people before you go into something …
you assume you’re not going to be one of those people …
it’s very hard to quantify what that means and how likely
something is’
Optimism bias, however, emerged as a common theme,
irrespective of indication for surgery.
‘… never looked at the negative side of it … I thought
it will work’
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One of the reasons for this optimism was that the surgeons
often appeared to downplay the risk of complications asso-
ciated with IBBR. Some women described how they would
have valued more information about the actual risks of
surgery rather than the general, almost paternalistic, reas-
surance they received.
‘I definitely feel like I would have appreciated more infor-
mation about … the risks … The probability of these
things happening rather than just … these things proba-
bly won’t happen to you’
Indeed, the majority of patients felt that the provision
of more realistic information about the potential risks
associated with IBBR could have enabled them to make
a more informed decision about surgery, even if their
ultimate decision did not change.
‘1 in 10, see I don’t know whether I was aware of that. I
don’t remember those figures … Yeah. I don’t remember
them saying too much about the risk. I think if I’d known
about that 1 in 10, perhaps I would have thought about it
a bit more. That’s quite a lot isn’t it?’
Full and frank discussion of the magnitude of the risks
involved was considered to be a very important, though
often lacking, component of the decision-making process.
Even patients undergoing IBBR for risk reduction, who
had more time to meet with their surgeon and discuss
their options, reported how discussions around the risks
associated with surgery did not occur.
‘Obviously, maybe if I had been given more information
on the after bit I might have been more prepared possibly
… I wasn’t a smoker. I wasn’t overweight. I was generally
quite healthy. I’ve got thyroid problems but that’s all under
control. Yes, I thought I was healthy. I was in my early 30s.
I thought those risks would be more likely if you were in
your 40s, overweight and a smoker. You know?’
Although accurate information about the magnitude of the
risks may not have changed many women’s decision to have
IBBR, it may have minimized their belief that they were to
blame for the loss of the implant.
‘… it’s my body, it’s my fault that I’ve lost them … I’ve
only ever met one person that’s lost their implants and I
didn’t realise it was 1 in 10’
Better information provision may also have minimized the
guilt that some women described as they blamed them-
selves for not asking the right questions before surgery.
‘I’ve got to take some responsibility myself … I should
have asked more questions, but it didn’t occur to me, and
I’m from a generation that, you know, doesn’t want to take
up people’s time, so I don’t want to be too questioning when
I’m with people who are incredibly busy’
In addition to more information from their surgical teams,
many women highlighted how much they felt they would
have benefited from other sources of information, in partic-
ular meeting other women who had undergone IBBR and
alternative reconstructive procedures, with both successful
and less successful outcomes.
‘And maybe … say groups … meetings or whatever with
other people in the same situation … I think you get a lot
out of that when you’re just talking to other people’
The need to empower patients to identify and act
on potential problems early
In addition to not fully understanding the likelihood of
experiencing a postoperative complication, the majority of
women felt they had not been given sufficient information
to identify and respond confidently to signs of complica-
tions with their implant.
A number of women described being uncertain about
how to interpret their concerns about their implant because
they did not expect problems to arise, given that clinicians
had emphasized the success rates of IBBR. The quality
of information provided at discharge was described by a
number of women as making it difficult for them to identify
and act on problems with the implant.
‘I had all that information but nothing I would say specific
about caring for the wound (except) … I had a dressing
and it wasn’t coming off’
Some women reported feeling unwell after surgery, but not
appreciating that this may represent a problem, such as
infection, with their reconstruction.
‘I just thought, oh, I’ve had an operation, I’m not taking
very well’
A number of women who did have concerns about their
implant described how they had found it difficult to access
help or to know who to ask in response to their concerns.
Some were dismissed.
‘… as I say, this is my first experience of being a patient,
I wasn’t very bolshy and confident, and I didn’t want to
bother people, so I was ringing up the breast care nurses
saying: “Who do I talk to?” – the breast care nurses said:
“Oh, your breast care nurse is on maternity leave, I can’t
really help you … and basically told me to go away’
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Other patients did not feel confident about raising their
concerns about their implant with clinicians.
‘I remember thinking, “It’s leaking. I’m not quite sure
what I need to do about this”, which is why I rang the
doctors … I think if the hospital had talked to me about
what to do about that, I wouldn’t have then thought to
myself, “Okay, what do I do about this now?”’
Uncertainty about how to identify problems with their
implant was related to feelings of self-blame by a number
of patients.
‘I just thought: “What have I done wrong? Have I done
something wrong?” … I thought, no … I’ve been very
careful … I think you do blame yourself’
Once a problem had developed, some women described
being seen by someone without specialist knowledge, such
a member of the on-call surgical team whom they felt, in
retrospect, did not manage them appropriately, and that
this may have influenced the outcome.
‘Over the weekend, underneath my left breast started to
look a bit red along one of the surgical wounds … So,
I came to the ward at the weekend, but I think it felt
like, perhaps, they weren’t particularly well set up for it,
because it was the general plastics registrar that I saw …
He had a look … and said, “No, it’s probably fine. They’ll
see you next week”. Knowing again what I know now,
having been through everything, I think I would probably
have asked him to call my surgeon, because I think I would
have started antibiotics then if it had been one of the breast
surgeons … ’
For some women, the infections that ultimately led to
implant loss went on for a protracted period of time, with
a significant impact on their psychological well-being.
‘I couldn’t talk without crying … lived 12months on
antibiotics … always in hospital … I got myself into a
very low place’
Other women described how some clinicians were reluc-
tant to make decisions, especially regarding implant
removal.
‘I wasn’t really happy just waiting to decide whether to
have it taken out … I got the impression nobody wanted
to make a decision’
In addition to more information about possible signs of
complications and better signposting to points of contact,
a number of women felt that, in retrospect, being seen
earlier in the postoperative period may have allowed their
problems to be detected sooner.
‘… it might have been appropriate to check the dressing
… after about a week or so rather than two weeks. I’m
not a medical person … but when I became aware that
something wasn’t quite right … I did have to wait a
couple of days or so before it actually got sorted’
The need to offer more support to patients after
implant loss
Psychological acceptance of losing their implant was
reported by some women. However, the majority felt
implant loss had affected them negatively, psychologically
and socially, and the lack of support available to them
during this time aggravated these adverse consequences.
‘Psychologically … like a new bereavement … I’m back
to square one again. I do feel quite low … ’
Even patients who felt well supported by family and friends
still reported sustained psychological distress following
implant loss.
‘Although I have got a very close family, I’ve, sort of,
lost – not lost the meaning of life; I’ve, sort of, lost all my
motivation to do anything good’
Manywomen described how implant loss impacted on their
body image.
‘… it was just looking down at it … And then when I
looked in the mirror, you know it was just horrible’
Others described how losing an implant affected their
lifestyle, and in some cases their livelihood.
‘… it cost me my job … I couldn’t go back to work. I
couldn’t deal with it mentally. Physically, I can’t stand up
properly’
For women who disclosed a pre-existing mental health
problem, losing their implant was perceived to have led to
a recurrence of the condition.
‘I have had depression and that actually did come back’
Some women blamed themselves for the complications
they experienced, and others described regretting their
decision to have implant-based reconstruction.
‘… looking back, it wasn’t a good decision, and when I’d
had the implant, just for those few days that I had the
implant, I knew it was wrong for me’
‘I think, oh it’s my body, it’s my fault that I’ve lost them’.
Although implant loss was described as affecting every
aspect of the women’s lives and was associated with signif-
icant psychological distress, the majority of women found
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Table 2 Recommendations for clinicians working with women undergoing implant-based breast reconstruction
Recommendations to improve decision-making and informed consent
Provide a balanced view of the risks and benefits of different types of reconstruction (including delayed options)
Provide realistic information about complications of implant-based reconstruction including implant loss rates as part of informed consent and
decision-making
Give patients time to make decisions
Avoid information overload
Consider written patient information including risks of complications and/or copying clinic letters to patients so they have a written summary of the
consultation and the risks discussed; see Appendix S2 (supporting information) for example of information sent to patients
If possible, offer patients the opportunity to speak with other women who have had reconstruction, support groups, or other patient-centred sources
of information
Recommendations to empower patients to recognize and act on possible complications
Clearly explain the risk of complications so that patients are aware these could happen and know to look out for them
Provide clear information about possible symptoms (including feeling non-specifically unwell)
Provide details of whom to contact if patients are concerned that they may have a problem (including out-of-hours and weekends), and make
sure the contact is appropriately skilled to give advice, or can and will access someone who is
Encourage and empower patients to get in contact and ask to be seen if they have any concerns, even if they are not sure – ‘better safe than sorry’
Consider safety-netting patients by seeing them more frequently (weekly or more) in the early postoperative period
Be honest and open with patients if you think there may be a problem
Involve patients in decisions about the timing of implant removal if this is likely to be needed – consider the impact of repeated courses of
antibiotics/admissions to attempt to save a reconstruction
Recommendations after implant loss
Offer patient-centred compassionate care
Make every contact count – offer emotional/psychological support – acknowledge the magnitude of the event and how it may have affected the
patient
Reinforce how to access available psychological support – signpost appropriate resources; offer referral if needed
Maintain contact with patients after discharge, and while awaiting secondary reconstruction
little support available to them once their implant had been
lost, with little or no contact initiated by clinical teams.
This led to some women feeling abandoned.
‘(after implant removed): They shook our hand and said,
“We’ll see you next year” … and I went, what do I do
now? I’ve come out of hospital yesterday … I didn’t know
what to do … I just felt cast out … there wasn’t really
any support there at all’
Specialist psychological support was perceived as needed
by the majority of patients after implant loss, but for many
this was missing from the care they were provided with.
‘I think it would have been useful to maybe been offered
for somebody to speak to, you know like some sort of like
psychological type of support’
A number of patients felt that a more empathic and
patient-centred approach was needed from clinicians man-
aging patients who had experienced implant loss, especially
when discussing further reconstructive procedures.
‘… for the surgeon, a little tweak is not very much – for a
patient that’s a whole … another waiting for a date …
time off work … being under anaesthetic, which is just
as significant almost as your initial operation … that’s
part of what needs to be up front … made a lot more
clear … how likely it is that you know you’ll need another
operation’
For women electing to undergo further reconstructive pro-
cedures, the uncertainty around waiting lists and further
surgery was also perceived as an additional stressor.
‘… living with uncertainty is very very uncomfortable
… when things go wrong and you’re having multiple
surgeries and you’re having to do that again and again
… it was probably two years by time and I had everything
sorted – that’s a long time to live with the anxiety of not
knowing what’s going to happen next’
This led to patients feeling dismissed or abandoned by their
surgeon after implant loss.
‘… I don’t feel like there was any support given from the
hospital itself, never got offered any … even if it was a
phone call or a letter just to stay that there’s still a waiting
list or something like that, instead of me feeling, and I still
feel like that, that they just forgot about it’
One participant summarized the improvements that are
needed when managing patients who have experienced
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implant loss, highlighting the need for compassionate
patient-centred care.
‘… perhaps this will highlight that through the whole
patient journey the healthcare experts involved need to
make every contact count in respect to emotions and coping
and offer … emotional and psychological support’
Recommendations for improving the experiences of
patients undergoing IBBR and implant loss on the basis of
these data are summarized in Table 2.
Discussion
Implant loss will affect almost one in ten women undergo-
ing implant-based reconstruction in the UK18, but this is
the first study to explore women’s experiences of implant
loss and how it impacts their quality of life. Key find-
ings were similar, irrespective of the indication for mas-
tectomy. They include: the need for accurate and balanced
presentation of the risks and benefits of implant-based
procedures to allow women to make fully informed deci-
sions about surgery; empowering women to recognize and
act on early warning signs of implant-related problems;
and the need to support women clinically and psycholog-
ically if they need to have their implant removed follow-
ing a postoperative complication. A more balanced dis-
cussion, including potential risks, may actually decrease
the number of implant-based procedures performed, as a
number of women in the study, particularly those having
surgery for malignancy, elected to undergo reconstruction
only because it was presented as a ‘quick and easy’ option.
Many of the issues identified could be addressed by better
communication, appropriate signposting, and focusing on
delivering compassionate, patient-centred care – ‘making
every contact count’. Implementing the simple recommen-
dations from this study into clinical practice would be a
major step towards significantly improving the experience
of implant loss for womenwho develop this potentially dev-
astating complication.
Implant loss is likely to become a major problem world-
wide as rates of implant-based breast reconstruction
continue to increase9,17. The growing magnitude of the
problem is reflected in the numbers of recent studies
reporting the clinical outcomes of autologous34–40 or
further implant-based41,42 reconstruction performed after
a failed implant-based procedure. Although the technical
success rates of further reconstructive surgery are high, few
studies have included patient-reported outcomes (PROs)
in their assessment of success43. The value of existing PRO
questionnaires in this group, however, is questionable,
as previous questionnaire-based breast reconstruction
studies44,45 have suggested that complications, including
implant loss, do not adversely affect women’s long-term
quality of life, in stark contrast to the present findings.
This may be because patients with complications such as
reconstructive failure do not self-identify as having had
a reconstruction, so elect not to participate; a number of
additional reasons for response bias in breast reconstruc-
tion studies have been reported recently46. The sensitivity
of existing PROmeasures, however, is an important consid-
eration for future research, asmany of the themes identified
in the present study, in particular the perceived lack of sup-
port following reconstruction failure, clearly resonate with
those identified in a similar qualitative study47 that explored
the impact of flap loss on patients undergoing autologous
reconstruction. The differences in the themes identified
between the two qualitative studies reflect key differences
in the procedures performed and timing of postoperative
complications, in particular that flap failure occurs while
patients are still in hospital. This means that patients
undergoing autologous reconstruction are not required
to recognize the signs of potential problems or know
when to seek help – a key finding in the present study.
The differences in satisfaction with information between
breast surgeons (largely performing implant-based recon-
struction in the UK) and plastic surgeons performing
free-flap procedures has been reported previously48. These
rich, clinically meaningful data suggest that qualitative
approaches may be a more appropriate method for explor-
ing this difficult and sensitive issue, and better quantitative
methods will be needed for use in future studies.
This study has highlighted several areas for improve-
ments in practice, but it has limitations. First, the recruit-
ment rate was low. Sixty-eight women from six centres
were invited to participate, but only 24 were interviewed
successfully. There is, therefore, likely to be response
bias in the study. It is not clear, however, whether the
women who elected not to participate did so because they
were more significantly affected by their implant loss than
those included, or whether they experienced better out-
comes and moved on with their lives. Further work in a
wider group is therefore needed to explore experiences of
implant loss. Recall bias, particularly with regard to infor-
mation provided about reconstruction, is also a possibility,
given the duration of time between implant loss and inter-
view (median 42months). All participants, however, clearly
described how implant reconstruction was presented as a
straightforward procedure; irrespective of whether specific
details were discussed, this potentially inaccurate represen-
tation of implant reconstruction had particular salience for
the women in the study, and is therefore likely to be an
accurate representation of their experiences. In addition,
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although every effort was made to sample study partici-
pants purposively, fewer patients undergoing risk-reducing
surgery and few patients who went on to have autologous
reconstruction were included in the present study. Again,
the reasons for this are unclear. It would be helpful to com-
pare the characteristics of those who agreed to participate
with those who did not, but ethical approvals did not per-
mit data collection on non-consenting patients, precluding
this analysis. Finally, the experiences of this limited cohort
may not be generalizable to women experiencing implant
loss in other centres across the UK. Participants, however,
were sampled purposively with respect to age, indication
for surgery and secondary reconstruction from six centres
at geographically diverse locations, and had been treated
by multiple surgeons at both local hospitals and regional
referral centres, suggesting the inclusion of a breadth of
perspectives and experiences. Interviews were continued
until data saturation was achieved, so it is unlikely that
additional participants from other centres would have iden-
tified significant further themes. Furthermore, the patient
experiences were triangulated with those of surgeons and
specialist nurses, both within the study team and through
presentation of key findings at an Association of Breast
Surgery annual conference. Feedback from meeting atten-
dees, both during the question-and-answer session and
informally after the presentation, confirmed the findings,
supporting the robustness of the present study49.
This qualitative work is the first phase of the LiBRA
study, which aims to use mixed methods to explore the
experiences of women who undergo implant loss after
immediate IBBR to inform the development of better
information and support for those who experience this
complication in the future. The simple recommendations
proposed based on this initial work represent significant
progress towards achieving this aim. Further work is now
needed to develop a questionnaire to explore the outcomes
of implant loss in a broader group of patients, to deter-
mine the extent to which the issues identified in the present
study are widespread and to identify additional areas where
improvement is required. Recognizing areas of good prac-
tice will also be a key element of the questionnaire study,
as these will form the basis of further recommendations
for information and support. Effective strategies to opti-
mize communication of risk, share information to empower
women to promote the early identification of complica-
tions, and encourage compassionate patient-centred care
for women who experience problems will then be needed
to improve outcomes for patients experiencing implant
loss in the future. Ultimately, however, rates of implant
loss in the UK18 are unacceptably high compared with
current best practice guidelines50. Research to identify
evidence-based best practice for IBBR18,51 and reduce
implant losses will therefore be themost important strategy
to improve outcomes meaningfully for patients electing to
undergo implant-based procedures in the future.
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